1023 related articles for article (PubMed ID: 8361317)
1. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
[TBL] [Abstract][Full Text] [Related]
3. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
[TBL] [Abstract][Full Text] [Related]
4. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
5. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
6. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors.
Chan WS; Marshall JF; Lam GY; Hart IR
Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641
[TBL] [Abstract][Full Text] [Related]
7. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
[TBL] [Abstract][Full Text] [Related]
8. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of murine skin tumors using Photofrin-II.
Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955
[TBL] [Abstract][Full Text] [Related]
12. Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour.
Yumita N; Umemura S
J Pharm Pharmacol; 2004 Jan; 56(1):85-90. PubMed ID: 14980005
[TBL] [Abstract][Full Text] [Related]
13. Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma.
Stukavec J; Horak L; Duchac V; Jirasek T; Rakusan J; Karaskova M; Pouckova P
Neoplasma; 2008; 55(2):127-9. PubMed ID: 18237250
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD-S31.
Date M; Sakata I; Fukuchi K; Ohura K; Azuma Y; Shinohara M; Matsuzaki K; Namiki Y; Takahashi H
Lasers Surg Med; 2003; 33(1):57-63. PubMed ID: 12866122
[TBL] [Abstract][Full Text] [Related]
15. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
Gayl Schweitzer V
Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
[TBL] [Abstract][Full Text] [Related]
16. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
Mosa M; Zitko M; Poucková P
Neoplasma; 1997; 44(3):178-83. PubMed ID: 9372860
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
18. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
Margaron P; Madarnas P; Quellet R; Van Lier JE
Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of pigmented choroidal melanomas.
Gonzalez VH; Hu LK; Theodossiadis PG; Flotte TJ; Gragoudas ES; Young LH
Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):871-8. PubMed ID: 7706035
[TBL] [Abstract][Full Text] [Related]
20. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]